ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 225 filers reported holding ZAI LAB LTD in Q3 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $673,282 | +8.3% | 20,243 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $621,460 | -34.2% | 20,243 | -26.7% | 0.00% | -50.0% |
| Q3 2022 | $944,000 | -1.5% | 27,616 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $958,000 | -21.2% | 27,616 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,215,000 | -30.0% | 27,616 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $1,736,000 | -40.3% | 27,616 | 0.0% | 0.01% | -44.4% |
| Q3 2021 | $2,910,000 | -40.5% | 27,616 | 0.0% | 0.01% | -43.8% |
| Q2 2021 | $4,888,000 | +32.6% | 27,616 | 0.0% | 0.02% | +23.1% |
| Q1 2021 | $3,685,000 | +34.8% | 27,616 | +36.8% | 0.01% | +30.0% |
| Q4 2020 | $2,733,000 | +62.7% | 20,194 | 0.0% | 0.01% | +42.9% |
| Q3 2020 | $1,680,000 | +1.3% | 20,194 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $1,659,000 | +59.5% | 20,194 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $1,040,000 | – | 20,194 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 106,171 | $2,938 | 14.16% |
| Genesis Investment Management, LLP | 1,352,222 | $37,420,559 | 4.06% |
| Segantii Capital Management Ltd | 1,795,479 | $49,788,633 | 2.59% |
| HSG Holding Ltd | 694,634 | $19,262,201 | 2.20% |
| Paradigm Biocapital Advisors LP | 865,297 | $23,994,686 | 1.85% |
| INDUS CAPITAL PARTNERS, LLC | 25,256 | $700,349 | 1.41% |
| Privium Fund Management B.V. | 240,683 | $6,366,065 | 1.34% |
| Vivo Capital, LLC | 445,505 | $12,353,854 | 0.85% |
| Rock Springs Capital Management LP | 1,222,423 | $33,897,790 | 0.81% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $2,189,505 | 0.67% |